OC-0480: Five-year clinical outcome of the Phase III ACCORD 12 neoadjuvant trial in rectal cancer. (April 2016) - Doyen, J.; Gourgou-Bourgade, S.; Azria, D.; Martel-Laffray, I.; Hennequin, C.; Vendrely, V.; De Laroche, G.; Conroy, T.; Gérard, J.P.